Biomarin Pharmaceutical shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $286k | 300k | 0.95 |
| 2024-06-30 | $287k | 300k | 0.96 |
| 2024-03-31 | $298k | 300k | 0.99 |
| 2023-12-31 | $310k | 300k | 1.03 |
| 2023-09-30 | $199k | 200k | 0.99 |
| 2023-06-30 | $202k | 200k | 1.01 |
| 2023-03-31 | $312k | 300k | 1.04 |
| 2022-12-31 | $321k | 300k | 1.07 |
| 2022-09-30 | $299k | 300k | 1.00 |
| 2022-06-30 | $300k | 300k | 1.00 |
| 2022-03-31 | $503k | 500k | 1.01 |
| 2021-12-31 | $521k | 500k | 1.04 |
| 2021-09-30 | $497k | 500k | 0.99 |
| 2021-06-30 | $504k | 500k | 1.01 |